FU. CREB critically regulates action potential shape and duration in the adult mouse ventricle. Am J Physiol Heart Circ Physiol 302: H1998 -H2007, 2012. First published March 16, 2012; doi:10.1152/ajpheart.00057.2011The cAMP response element binding protein (CREB) belongs to the CREB/ cAMP response element binding modulator/activating transcription factor 1 family of cAMP-dependent transcription factors mediating a regulation of gene transcription in response to cAMP. Chronic stimulation of ␤-adrenergic receptors and the cAMP-dependent signal transduction pathway by elevated plasma catecholamines play a central role in the pathogenesis of heart failure. Ion channel remodeling, particularly a decreased transient outward current (Ito), and subsequent action potential (AP) prolongation are hallmarks of the failing heart. Here, we studied the role of CREB for ion channel regulation in mice with a cardiomyocyte-specific knockout of CREB (CREB KO). APs of CREB KO cardiomyocytes were prolonged with increased AP duration at 50 and 70% repolarization and accompanied by a by 51% reduction of I to peak amplitude as detected in voltageclamp measurements. We observed a 29% reduction of Kcnd2/Kv4.2 mRNA in CREB KO cardiomyocytes mice while the other I to-related channel subunits Kv4.3 and KChIP2 were not different between groups. Accordingly, Kv4.2 protein was reduced by 37% in CREB KO. However, we were not able to detect a direct regulation of Kv4.2 by CREB. The I to-dependent AP prolongation went along with an increase of I Na and a decrease of ICa,L associated with an upregulation of Scn8a/Nav1.6 and downregulation of Cacna1c/Cav1.2 mRNA in CREB KO cardiomyocytes. Our results from mice with cardiomyocyte-specific inactivation of CREB definitively indicate that CREB critically regulates the AP shape and duration in the mouse ventricle, which might have an impact on ion channel remodeling in situations of altered cAMP-dependent signaling like heart failure. ion channel remodeling; heart; transcriptional regulation; adenosine 3=,5=-cyclic monophosphate response element binding protein; transient outward current
THE CARDIAC ACTION POTENTIAL (AP) shape and duration are determined by the interplay of inward and outward ion currents. The rapid AP upstroke reflects inward Na ϩ current (I Na ) mainly through the voltage-dependent Na v 1.5 channel (28, 29) . Depolarization then again activates Ca 2ϩ current (I Ca,L ) through the L-type voltage-gated (Ca v 1.2) Ca 2ϩ channel (4). The major determinants of AP repolarization in the myocardium are voltage-gated K ϩ channels. They can be divided in two functional groups, the rapidly activating and inactivating transient outward currents (I to ) and the delayed rectifiers (I K ; Ref. 36) . In ventricular cardiomyocytes, the activation and inactivation characteristics of I to are particularly important for the modulation of the early phase of AP repolarization and of excitation-contraction coupling (29, 33, 42) . Prominent I to currents are present in ventricular cardiomyocytes of most mammalian species, including mouse, rat, rabbit, canine, and human. Two distinct I to currents can be distinguished based on their biophysical properties leading to anatomical heterogeneities of the AP waveform. The I to,fast (I to,f ) recovers rapidly, while I to,slow (I to,s ) recovers slowly with time constants in the order of seconds (2, 36, 52) ; in the mouse, I to,s is only expressed in septal myocytes (52) . On the molecular level, I to,f and I to,s underlying channels are encoded by the potassium voltage-gated channel subfamily D member 2 (Kcnd2/Kv4.2) and member 3 (Kcnd3/Kv4.3), the Kv channel-interacting protein 2 (Kcnip2/KChIP2), and potassium voltage-gated channel, shaker-related subfamily, member 4 (Kcna4/Kv1.4) subunits, respectively (for review, see Ref. 5) . The knockdown of either Kcnd2 or Kcnd3 reduces I to by 50% in rat ventricular cardiomyocytes (6) whereas the lack of KChIP2 leads to a complete loss of I to in cardiomyocytes and a marked increase in AP duration (14) . In mouse ventricle, the delayed rectifiers are represented by the potassium voltage-gated channel, shakerrelated subfamily, member 4 (Kcna5/Kv1.5)-based I K,slow1 (16) , and the potassium voltage gated channel Shab-related subfamily member 1 (Kcnb1/Kv2.1)-based I K,slow2 (53) .
Ion channel remodeling, in particular a decreased I to , and subsequent AP prolongation are hallmarks of the failing heart and heart failure (HF)-related arrhythmias and are associated with the occurrence of afterdepolarizations and triggered arrhythmia (1, 27) . HF is defined as the heart's inability to cover the body's blood demand and is the common end stage of various cardiac diseases including ischemic or dilated cardiomyopathy. HF is among the leading causes of death in Western countries, 50% of HF patients die within 3-4 yr after diagnosis. The arrhythmic "sudden cardiac death" accounts for 30 -50% of these fatal casualties (1, 19, 24) . Chronic stimulation of ␤-adrenergic receptors and the cAMP-dependent signal transduction pathway by elevated plasma catecholamines play a central role in the pathogenesis of HF (for review, see Ref. 20) . However, mechanisms underlying the altered gene regulation in failing hearts including alterations associated with ion channel remodeling are not known in detail. The transcription factors of the cAMP response element binding protein/modulator and activating transcription factor 1 (CREB/CREM/ ATF1) family are expressed in the heart (25, 26) and mediate the regulation of gene transcription in response to cAMP by binding to cAMP responsive elements (CREs, TGACGTCA, and variants thereof) in the promoter region of target genes (for review, see Ref. 23 ). The inactivation of CREM partially protects from ␤-adrenoceptor-mediated detrimental effects in the mouse heart (15) . Mice with a cardiomyocyte-specific inactivation of CREB were investigated before in our group. CREB-deficient mice were viable and displayed neither changes in survival, cardiac morphology, nor alterations of basal or isoproterenol-stimulated left ventricular function in vivo at an age of 16 -24 wk (22) . However, the consequences of CREB inactivation in the heart for cellular electrophysiology were not investigated. Here, we studied whether CREB is involved in the regulation of cardiac ion channels underlying AP shape and duration.
MATERIAL AND METHODS
Experimental animals. Mice with a cardiomyocyte-specific ablation of CREB (CREB KO) using the Cre-loxP system were described previously (22) . They lack Creb1 exon 10 resulting in a truncated CREB protein without DNA-binding and dimerization domains. Mice not expressing Cre recombinase (i.e., with functional CREB) from the same breeding colony were employed as controls (CTR). Experimental animals were 12 to 18 wk old and from generation F8 or more to ensure genetic homogeneity. All animal procedures were conducted in accordance with local animal welfare authorities and approved by the Landesamt Für Natur, Umwelt und Verbraucherschutz, NordrheinWestfalen.
Isolation of adult mouse cardiomyocytes. Adult cardiomyocytes were isolated from adult (12 to 18 wk) CREB KO and CTR mice by enzymatic digestion as described before (12) . Briefly, excised hearts were rinsed with heparin and then retrogradely perfused with collagenase solution (Type II, Worthington Biochemical) in a modified Langendorff apparatus (37°C, 2 ml/min). Cells were then separated by mechanical dispersion and prepared as needed for subsequent experimental procedures.
For patch-clamp experiments, cardiomyocytes were gently centrifuged (42 relative centrifugal force/min) to separate vital myocytes from nonmyocytes. After stepwise elevation of extracellular Ca 2ϩ to 1 mM, cells were immediately used for experiments within 6 h after isolation.
Cellular electrophysiology. APs and membrane currents were recorded in whole cell configuration using the perforated patch technique with amphotericin B (38) . Calcium-tolerant, rod-shaped, and clearly striated ventricular myocytes were selected randomly for electrophysiological studies at room temperature (22-24°C) . Patch pipettes were pulled (P97; Sutter, Novato, CA) from borosilicate glass capillaries (Science Products, Hofheim, Germany) with a 1.5-mm diameter. Pipette resistances were 3-5 M⍀ when filled with pipette solution. Recordings were performed using a List Medical L/M-PC PC (List Medical, Lambrecht, Germany) interfaced and controlled by an ISO2-recording system (MFK Friedrich, Niedernhausen, Germany) or an EPC 800 Patch Clamp Amplifier and PatchMaster Software (HEKA Elektronik, Lambrecht, Germany). Cell capacitance was determined by ramp pulses before capacitance compensation. Cell capacitance and series resistance were carefully compensated before recording start. Recordings with series resistance Ͼ20 M⍀ were discarded. The recording of sodium currents was performed using a SEC-05X discontinuous single-electrode voltage-clamp amplifier (NPI, Tamm, Germany) to exclude series resistance errors, which are especially problematic when large currents are recorded.
APs were evoked by injecting suprathreshold current pulses in current-clamp mode at a 1-Hz stimulation frequency. Potassium currents were evoked by a step protocol from Ϫ40 to ϩ60 mV (⌬10 mV, 4.5-s duration) from a holding potential (HP) of Ϫ80 mV. Na ϩ currents were suppressed by applying a brief prepulse to Ϫ40 mV (10 ms) before each test pulse. The transient outward current I to was separated by applying a 100-ms lasting prepulse to Ϫ40 mV (HP: Ϫ80 mV) and subtracting respective traces from currents recorded without prepulse as described by Brouillette et al. (3) (see Fig. 2 ; Millipore, Schwalbach/Ts., Germany) was treated the same as Kv4.2. Briefly, membranes were blocked with 5.0% dry fat milk in PBS with 0.025% sodium-azide overnight at 4°C. The first antibody was pretreated 1 h in 0.5 ml PBS-1% BSA, centrifugated, and diluted with 4.5 ml blocking solution. The blocked membranes were incubated for 2 h in the antibodyblocking solution and washed four times in PBS-0.1% Tween-20 without sodium-azide. Secondary anti-rabbit antibody (1:5,000, ECL rabbit IgG, HRP-Linked Whole Ab; GE Healthcare, Freiburg, Germany) was applied for 1 h at room temperature in PBS-0.1% Tween-20. For blocking GAPDH (1:10,000, ab9485; Abcam, Cambridge, MA), CSQ (1:2,500, PA1-913; Thermo Fisher, Bonn, Germany), and KChIP2 (1:200, KChIP2 H-100, sc-25685l; Santa Cruz Biotechnology, Heidelberg, Germany) membranes were treated in TBS containing 5.0% dry fat milk for 2 h and washed four times for 10 min in TBS-0.1% Tween-20 (TBS-T), incubated 2 h at room temperature or overnight at 4°C with the primary antibody in TBS, followed by being washed four times with TBS-T. The corresponding secondary antibodies anti-mouse-IgG (1:20,000, ECL Mouse IgG, HRP-Linked Whole Ab; GE Healthcare) for detection of GAPDH and anti rabbitIgG (1:10,000 for detection of CSQ and 1:3,000 for detection of KChIP2) were incubated for 2 h at room temperature and washed four times with TBS-T. The amount of protein loaded was within linear range of the determination. The detected bands of Kv4.2 and Kv4.3 were blocked by the specific antigens provided by the manufacturer's instructions (not shown). Signals were visualized and quantified by using the ECL plus detection system (Amersham ECL Plus; GE Healthcare) by using the STORM blot imaging system (Molecular Dynamics, Sunnyvale, CA). CREB KO and CTR cardiac left ventricular homogenates were loaded in an alternating manner, and variabil-ity was controlled by using CSQ and GAPDH as standard proteins and presented relative to the CTR homogenates.
Quantitative real-time RT-PCR. Total RNA was extracted from cardiac ventricles or cardiomyocytes of CREB KO and CTR mice with the use of Trizol (Life Technologies, Darmstadt, Germany). Total RNA (0.5 g) was randomly reversely transcribed to cDNA using the first-strand cDNA synthesis kit for RT-PCR AMV (Roche, Mannheim, Germany). The real-time RT-PCR was carried out using a LightCycler 1.5 System (Roche), and the detection was performed by measuring the binding of the fluorescence dye SYBR Green I to double-stranded cDNA at 530 nm (QuantiFast SYBR Green PCR kit; Qiagen, Hilden, Germany). Primers (Life Technologies) were designed using Primer3 (http://frodo.wi.mit.edu/; Ref. 40 ) with standard configuration except: "Mispriming Library" was set to "Rodent end Simple" and "Product Size" was limited to 100 -300 bp. The PCR reactions were set up in microcapillary tubes in a volume of 20 l. The reaction components were 2 l undiluted cDNA, 10 l QuantiFast SYBR Green PCR Master Mix, 4 l H 2O, and 2 l for each primer (10 pM). Reactions were incubated at 95°C for 5 min followed by 50 cycles at 95°C for 5 s, 60°C for 15 s, and 72°C for 10 s. Relative levels of particular cDNAs were determined with the help of LightCycler software (version 3.5) with appropriate calibration curves obtained with different amounts of control cDNAs. Crossing points were determined by using the second derivative method. On completion of the PCR amplification, a melting curve analysis was performed. Relative quantification was performed by calculating relative expression ratios using the ⌬⌬C T method and the relative expression software tool (REST Version 2.013; see refs. 18, 37, 46) . Random statistical analysis was performed with 10,000 iterations, and hypoxanthine guanine phosphoribosyl transferase (Hprt) was used as a reference gene.
Chromatin immunoprecipitation. The chromatin immunoprecipitation (ChIP) was adapted from published protocols (31, 44) . Mouse hearts were frozen in liquid nitrogen, crushed with a pestle, and mechanically homogenized (Polytron PT 3000; Kinematica, Luzern, Switzerland) in ice cold PBS with proteinase inhibitors (Complete Mini-protease inhibitor cocktail tablets; Roche). After a 5-min centrifugation at 5,000 g, the supernatant was discarded and formaldehyde was added at a final concentration of 1% at room temperature. After a 30-min crosslinking, the reaction was stopped by the addition of glycine to a final concentration of 0.125 M. The cells/cell aggregates were collected by centrifugation (10 min at 5,000 g), rinsed in PBS at 4°C, and again centrifugated. The pellets were resuspended in cell lysis buffer (5 mM PIPES, 85 mM KCl, and 0.5% NP40 pH 8.1, with proteinase inhibitors), incubated on ice for 40 min, and shortly dounce homogenized. Pellets containing the nuclei were collected by centrifugation (8,000 g for 10 min) and then resuspended and incubated for 30 min in 1 ml sonication buffer (1% SDS, 10 mM EDTA, and 50 mM Tris·HCl pH 8.1, with proteinase inhibitors). The samples were sonicated on ice with a Virsonic 60 (Virtis) setting to 4 W for 5 ϫ 10 s pulses generating overlapping DNA fragments of an average length of ϳ500 -700 bp. The probe was then centrifuged for 5 min at 13,000 g, and the supernatant was precleared with the addition of 80 l protein A/G (50/50%)-agarose beads (protein A-agarose, protein G-agarose fast flow; Millipore) for 1 h at 4°C. Before use, the agarose beads were blocked with 0.024% glycogen and 0.5% bovine serum albumin overnight at 4°C. Two-hundred microliters of the precleared chromatin were filled up to 1 ml with ChIP dilution buffer (0.01% SDS, 1.1% Triton-X-100, 1.2 mM EDTA, 16.7 mM Tris·HCl pH 8.1, and 167 mM NaCl), incubated with 10 g of affinity-purified rabbit polyclonal CREB antibody (anti-CREB 06 -863; Millipore) or a rabbit IgG antibody (normal rabbit IgG 12-370; Millipore), and rotated at 4°C overnight. For immunoprecipitation, the probes were incubated with 80 l blocked agarose beads for 2 h at room temperature and centrifugated at 150 g, and the supernatant was discarded. Then, the beads were washed with 500 l low-salt buffer (0.1% SDS, 1% Triton-X-100, 2 mM EDTA, 20 mM Tris·HCl pH 8.0, and 150 mM NaCl); high-salt buffer (0.1% SDS, 1% Triton-X-100, 2 mM EDTA, 20 mM Tris·HCl pH 8.0, and 500 mM NaCl); LiCl buffer [250 mM LiCl, 1% Nonident 40, 1% deoxycholic acid (sodium salt), 1 mM EDTA pH 8.0, and 10 mM Tris·HCl pH 8.0]; and two times with TE buffer (1 mM EDTA and 20 mM Tris·HCl pH 8.0). After each washing step, the slurry was centrifugated at 150 g for 1 min and the supernatant was discarded. After being washed, the immune complexes were eluted by a 15-min incubation of the agarose beads with 150 l fresh elution buffer (1% SDS and 0.1 M NaHCO3), centrifugation at 150 g, and collection of the supernatant followed by a second incubation with 100 l elution buffer and centrifugation. The collected supernatants were combined and crosslinks were reversed by the addition of 20 l 5 M NaCl per sample and a subsequent incubation at 65°C for 6 h. Then, the samples were incubated with 2 l proteinase K (10 mg/ml) and 2.5 l RNase (10 mg/ml) for 1.5 h at 55°C. The DNA was extracted by a PCR-purification kit (Qiagen) and amplified by a whole genome amplification Kit [GenomePlex Complete Whole Genome Amplification (WGA2) Kit, Sigma-Aldrich, München, Germany] according to the manufacturer's instructions. For real-time PCR analysis, the amplified probes were diluted 1:10 and 1 l was used for analysis. Primers were for the glyceraldehyde-3-phosphate dehydrogenase (Gapdh) promoter F-5=-caattccccatctcagtcg-3=, R-5=-cctactttctccccgcttt-3=; and for the FBJ osteosarcoma oncogene (Fos) promoter F-5=-tgccaagacgggggttgaaag-3=, R-5=-cctactactccaaccgcgactgca-3=. To detect a possible enrichment of the precipitated DNA fragments from the potassium voltage-gated channel, Shal-related family, member 2 (Kcnd2) gene promoter, the following three primer pairs were used: Ϫ2,131 to Ϫ1,940 bp: (Kcnd2-2,131) F-5=-ttagatatgggcagggatgc-3=, R-5=-attacccgtccaacttgctg-3=; Ϫ1,052 to Ϫ874 bp (Kcnd2-1,052): F-5=-tttgggaaggtgacaaggag-3=, R-5=-ggggctgagttgcatagaga-3=; and Ϫ694 to Ϫ495 bp (Kcnd2-694): F-5=-agagggtgtcagtcgtcgtt-3=, R-5=-ccaaaggcgtctcaaaaaga-3=. Numbers indicate the distance to the ATG start codon. Since precipitated DNA fragments have an approximate size of 500-to 700-bp detection by real-time RT-PCR with the chosen primer pairs (amplifying ϳ200-bp regions) would detect an enrichment of DNA fragments in the whole promoter region.
Plasmid construction. For reporter plasmid construction: a genomic fragment of the Kcnd2 gene promoter was amplified via PCR using the following primers: (Kv42-Xho_For) F-5=-ctcgaggttgaacttgttgctgttggct-3= and (Kv42-Hind_Rev) R-5=-atgaagcttggaagtggaggtcacgagagt-3=. After XhoI/HindIII digestion, this fragment was cloned into the luciferase gene containing vector pGL4.16 (Promega, Madison, WI), which was also cut by XhoI and HindIII (resulting plasmid: pKv4.2minLuc). A second fragment lying upstream of the first fragment was synthesized (Mr. Gene, Regensburg, Germany) and digested by KpnI and XhoI. This fragment was inserted into pKv4.2minLuc digested by KpnI and XhoI (resulting plasmid: pKv4.2Luc). Finally, the reporter gene construct contains a genomic region starting 2,541 bp upstream of the Kcnd2 start codon.
Reporter gene assay. Human embryonic kidney 293 (HEK293) cells were maintained in DMEM supplemented with 10% (vol/vol) FCS, 100 U penicillin, and 0.1 mg streptomycin per ml, and 7 mM glutamine (all PAA, Pasching, Austria) at 37°C in an atmosphere of 5% CO2. HEK 293T cells were transfected using TurboFect in vitro transfection reagent (Fermentas, St. Leon-Roth, Germany) according to manufacturer's protocol. For transfection, cells were maintained in 24-well plates (Corning, Hagen, Germany) and each well was cotransfected with 300 ng of pKv4.2minLuc and 10 ng of a Renilla reniformis luciferase gene containing construct (pRL-CMV; Promega). Additionally, the cells were transfected with 50 ng of the expression plasmid pcDNA3 (Life Technologiey) containing either the mCherry open reading frame (control) or the dominant negative CREB encoding ORF (45) . Twenty-four hours posttransfection cells were lysed and assayed using the Dual-Luciferase Reporter Assay System (Promega) as described in the manufacturer's protocol. Luciferase activities were determined by a Mithras LB 940 Microplate Analyser (Berthold technologies, Bad Wildbad, Germany). All luciferase results were normalized against the renilla luciferase activity as an internal control.
Statistical analysis. If not indicated otherwise data are presented as means Ϯ SE or boxplots indicating the 10th and 90th percentile (whiskers), the 25th and 75th percentile (lower and upper end of the boxes) and the median (horizontal line in the box). The number of experiments are reported as n ϭ number of measurements/number of independent experiments. Statistical evaluation was performed using two-way ANOVA with post hoc testing according to Bonferroni. Post hoc testing was performed only if the preceding pro-omnibus test revealed significant differences between groups. For comparison of two groups, a Mann-Whitney-rank sum test was conducted. Statistical analysis of real-time RT-PCR data in Tables 1 and 2 was performed using REST software (REST Version 2.0.13; see ref. 37, 46) . Figure 1A shows superimposed representative AP recordings from CREB KO and CTR cardiomyocytes and displays AP prolongation in CREB KO myocytes. Analysis of AP duration parameters (Fig.  1D ) revealed an increased AP duration at 50 and 70% repolarization (APD 50 and APD 70 ) in CREB KO while APD 90 was Calculation of relative expression ratios using hypoxanthine guanine phosphoribosyl transferase (Hprt) mRNA as reference gene and statistical randomization test analysis (10,000 iterations) were performed by the relative expression software tool (REST 2009 Version 2.0.13). Note the significant downregulation of Kcnd2, Cacna1c, and Crem ICER and the upregulation of Scn8a and Crem 3=-untranslated region (UTR) in the cAMP response element binding protein knockout (CREB KO) mice compared with the control (CTR) mice. F, forward; R, reverse. *P Ͻ 0.05 vs. CTR. At the same time, the AP amplitude (Fig. 1B) was enhanced in CREB KO while resting membrane potential (RMP; Fig. 1C ) was unaltered between groups (CREB KO vs. CTR, in mV: amplitude 127 Ϯ 3* vs. 117 Ϯ 3 and RMP Ϫ72 Ϯ 1 vs. Ϫ71 Ϯ 1; *P Ͻ 0.05 vs. CTR).
RESULTS

APs are prolonged in CREB KO cardiomyocytes.
I Na peak amplitude is increased in CREB KO cardiomyocytes. Sodium currents (I Na ) were recorded by use of a discontinuous single-electrode voltage-clamp amplifier and a low-sodium extracellular solution to exclude voltage clamp errors caused by series resistance. I Na peak amplitudes recorded under these conditions were increased in CREB KO cardiomyocytes as demonstrated by respective I-V curves (Fig. 2A) . The current increase was significant for voltages between Ϫ50 and Ϫ10 mV (two-way ANOVA with repeated-measures, Bonferroni post hoc test) on average 30% in this range and might explain the enhanced AP amplitude observed in CREB KO cardiomyocytes aside from a contribution to AP prolongation. The increased I Na amplitude was associated with an upregulation of sodium channel, voltage-gated, type VIII, ␣ (Scn8a/Nav1.6) mRNA but an unaltered sodium channel, voltage-gated, type V, ␣ (Scn5a/Nav1.5) mRNA level (Table 1) in CREB KO cardiomyocytes.
I Ca,L peak amplitude is decreased in CREB KO cardiomyocytes. Unexpected with regard to the AP prolongation in CREB KO, we found the peak amplitude of I Ca,L reduced in CREB KO cardiomyocytes. The reduction was significant for voltage steps from Ϫ10 mV to ϩ40 mV (two-way ANOVA with repeated-measures, Bonferroni post hoc test) and on average 45% (Fig. 2B) . The level of calcium channel, voltagedependent, L-type, ␣1C subunit (Cacna1c/Cav1.2) mRNA was at the same time reduced in CREB KO cardiomyocytes, whereas mRNA levels of Cacnb1 and Cacnb2 (L-type calcium channel subunit ␤-1 and -2) were not altered.
I to peak amplitude is attenuated in CREB KO cardiomyocytes. Recording of total outward potassium currents from CREB KO and CTR cardiomyocytes revealed reduced peak amplitude of total outward potassium currents in CREB KO cardiomyocytes (Fig. 2E) . Because the total outward K ϩ current amplitude consists of up to four different components, I to was separated from overlaying currents using a prepulse protocol (Fig. 2, C  and D) . The separated I to peak amplitude was decreased in CREB KO cardiomyocytes to average by 51% (Fig. 2F) (Fig. 3, A and B, and Table 1 ). Genes of other regulatory subunits of the I to,f namely Kcnd3/Kv4.3 and Kcnip2/KChIP2 did not show changes in their expression levels either in ventricular homogenates or in cardiomyocytes (Fig. 3, A and B, and Table 1 ). Moreover, no changes in the expression of Kcna4/Kv1.4, Kcna5/Kv1.5 and Kcnb1/Kv2.1, the underlying subunits of I to,s , I K,slow1 and I K,slow2 , respectively, were observed (Table 2) . Consistent, with the mRNA expression analysis, Western blot analysis of Kv4.2 protein levels were significantly downregulated by 37% in the myocardium of CREB KO vs. CTR mice, whereas Kv4.3 and KChIP2 protein content was not different between the genotypes (Fig. 3, C and D) .
Direct regulation of the Kcnd2 promoter by CREB was not detected. Downregulation of Kcnd2 mRNA and protein levels raised the question if CREB directly interacts with the Kcnd2 promoter and regulates its activity. The Kcnd2 promoter exhibits no conserved full or half site CRE elements. ChIP with a CREB antibody revealed no enrichment of DNA Kcnd2-promoter fragments in the mouse ventricle, using primer pairs covering the Kcnd2 promoter (Kcnd2-694 1.2 Ϯ 0.6, Kcnd2-1053 1.4 Ϯ 0.7, and Kcnd2-2131 1.3 Ϯ 0.7; n ϭ 4; Fig. 4A ; for details, see MATERIALS AND METHODS), whereas a promoter region carrying a CREB binding CRE site from the Fos gene as a positive control showed a strong enrichment 183 Ϯ 92 fold . ICa,L peak amplitude was reduced in CREB KO cardiomyocytes by ϳ45% (cells/animals: black squares, CTR, n ϭ 12/4; gray squares, CREB KO, n ϭ 17/3). C and D: pulse protocol and separation procedure to separate the transient outward current (Ito). A classic step protocol (Ϫ40 to ϩ60 mV, ⌬10 mV, HP: Ϫ80 mV) was used to evoke total outward potassium currents and then the same protocol was applied a second time with a preceding prepulse to Ϫ40 mV for 100 ms (C). Resulting currents of both protocols were subtracted from each other (D). Resulting array represents the separated Ito. E: I-V curves of total peak potassium outward current (IK) illustrate a reduction of total peak potassium outward current in CREB KO cardiomyocytes. F: I-V curves of the separated Ito peak amplitude. Ito peak amplitude was reduced in CREB KO cardiomyocytes. Average reduction in CREB KO amounted to 51% of CTR cardiomyocytes (cells/animals: black squares, CTR, n ϭ 10/6; gray squares, CREB KO n ϭ 8/3). *P Ͻ 0.05, two-way ANOVA with repeated-measures, Bonferroni post hoc test.
(n ϭ 4; P Ͻ 0.05 vs. CTR), proving the functionality of the ChIP with the CREB antibody.
Since regulation of the Kncd2 promotor activity by CREB could be possible via nonconserved binding sites, we generated a reporter gene construct containing 2,541 bp of the Kcnd2 5=-UTR and tested whether overexpression of a dominant negative CREB (dnCREB) isoform has an impact on the promoter activity. The dnCREB contains a Ser-133 to Ala substitution and functions as a potent dominant negative repressor of CREB-dependent gene expression both in vitro and in vivo (5, 45) . Overexpression of the dominant-negative CREB isoform dnCREB has no impact on the reporter activity (n ϭ 24/4).
Altered regulation of the cAMP transcription factor family members. To evaluate a possible compensatory role of cAMP transcription factor family members, namely CREM and ATF1, mRNA levels of Crem splice variants and Atf1 were determined (Table 1) . A specific primer pair (Crem ICER) for the CREM-inducible cAMP early repressor splice variants Icer I and Icer II revealed a downregulation of mRNA of 29% in CREB KO cardiomyocytes. The mRNA level was quantified by a primer pair (Crem 3=-UTR) recognizing several other transcript variants of Crem (e.g., Crem␣) was upregulated twofold, whereas Atf1 transcripts were not altered.
DISCUSSION
Our results show that the inactivation of transcription factor CREB leads to prolongation of the early phase of the AP by the regulation of underlying currents. The AP prolongation is mainly carried by a downregulation of the I to underlying channel subunit Kv4.2 and a subsequent reduction of the transient outward current (I to ) in adult mouse ventricular cardiomyocytes but also accompanied by an increase of I Na along with an upregulation of Scn8a/Nav1.6 and decrease of I Ca,L along with a downregulation of Cacna1c/Cav1.2. This indicates CREB as an important regulator of AP shape and duration in the mouse heart.
In contrast to the human cardiac ventricular AP, the mouse ventricular AP is rather short lacking a marked plateau phase and is characterized by a rapid repolarization phase mainly determined by the transient outward current I to and a less marked L-type Ca 2ϩ current (28) . I to activates and inactivates fast, which made this current the most important candidate for explaining the observed AP prolongation in CREB KO cardiomyocytes; other major repolarizing K ϩ currents like the delayed rectifiers I K,slow1 and I K,slow2 rather determine the later repolarization phase of the AP (16). After measuring a peak amplitude reduction of total potassium outward current in CREB KO, we indeed detected a marked reduction of the I to peak amplitude in CREB KO cardiomyocytes along with the observed AP prolongation. The reduced I to together with the detected increase in I Na can also well explain the increased AP amplitude in CREB KO cardiomyocytes since the amplitude of the AP is mainly determined by the influx of Na ϩ ions and the counteracting I to . Furthermore, the increased I Na may contribute to the AP prolongation itself. Interestingly, we detected an upregulation of Scn8a mRNA encoding the brain type Na ϩ channel subunit Na v 1.6 while the level of Scn5a encoding the predominant cardiac Na ϩ channel subunit Na v 1.5 remained unchanged. Recent studies describe the importance of Na v 1.6 in the mouse heart for AP propagation, excitation-contraction coupling (30) and its upregulation in a rat pressure-overload model (50) . Unexpected with regard to the extended AP duration was the observed I Ca,L reduction in CREB KO car- diomyocytes along with a reduction of the Ca v 1.2 encoding mRNA Cacna1c. One may speculate that the AP prolongation would have been more pronounced with an unaltered I Ca,L amplitude in CREB KO. The electrophysiological data are strongly supported by the data concerning Kcnd2/Kv4.2 mRNA and protein levels. In mice, I to,f is composed of Kv4.2 and Kv4.3 ␣-subunits and the accessory subunit KChIP2, whereas Kv4.2 is the major determinant of regional heterogeneities of I to,f expression in the adult mouse ventricle (10) . CREB-deficient mice showed a significant decline in cardiac Kcnd2 mRNA and protein content compared with control animals. In line with our findings, a deletion of the Kcnd2 gene in the mouse eliminates the ventricular I to,f underlining the critical role of Kv4.2 in the generation of the I to,f in rodents (9) . Other publications reported that in large mammals like dogs and humans Kv4.3 seems to play the major role for I to generation (13, 47) . On the other side, an absence of KChIP2 can lead to a complete loss of I to in mouse cardiomyocytes and a marked increase in AP-duration, while RNA and protein levels of Kcnd2/Kv4.2 and Kcnd3/Kv4.3 remain unchanged (14) . However, we found no altered mRNA-and protein levels of other I to subunits namely Kcnd3/Kv4.3 and Kcnip2/KChIP2, suggesting that the downregulation of Kcnd2/Kv4.2 mRNA and protein level was exclusively responsible for the decreased I to and the enhanced AP duration in CREB KO mice. Previous studies (34, 35) indirectly linked CREB to the regulation of I to and I to underlying subunits: a downregulation of the I to and a decrease of Kv4.3 and KChIP2 went along with reduced CREB protein levels after ventricular pacing in the canine heart. Moreover, a decreased phosphorylation of the extracellular signal-regulated kinase (ERK) and CREB was associated with a decrease in I to and a decline of Kv4.2 and KChIP2 protein content (39) in a model of pharmacologically induced nerve sprouting in rats. However, we were not able to detect direct CREB binding to the promoter of Kcnd2/Kv4.2 in the mouse heart with ChIP nor a reduction of the Kcnd2/Kv4.2 promoter activity in HEK cells after overexpression of a dominant negative CREB mutant (dnCREB; Ref. 5), which suppresses CRE-mediated transcriptional activation. This implies an indirect regulation of Kv4.2 and hence I to by CREB in mice.
It has been shown that activation of the nuclear factor of activated T-cells (NFAT) pathway leads to downregulation of Kv4.2 in the mouse heart (51). In the literature, CREB and NFAT are regarded as opponents, e.g., for cell cycle quiescence vs. hypertrophic growth and cell cycle progression (8, 17) . There are several proteins (7, 32, 43, 49) interacting with both CREB and NFAT, e.g., the phosphatase calcineurin (Ppp3ca), which activates NFAT and inactivates CREB by dephosphorylation (8) . Therefore, the loss of CREB might influence the balance between CREB and NFAT signaling resulting in preference of the NFAT pathway in our model. Furthermore, the inactivation of CREB might alter the expression of proteins involved in the regulation of calcium signaling, thereby activating the NFAT pathway. According to the literature, a prolongation of the early phase of the AP may also lead to an activation of calcineurin/NFATc3. In detail, cardiomyocytes from mice expressing a truncated Kv4.2 protein showed AP prolongation resulting in an elevated total Ca 2ϩ entry and increased Ca 2ϩ transient amplitude (41) . The hearts of these mice developed cardiac hypertrophy with chamber dilatation by 13 to 15 wk of age (48) , which could be prevented by calcineurin inhibition or Ca 2ϩ channel blockade. These findings were also supported by a study on neonatal rat cardiomyocytes investigating the role of Kv4.2-based I to reduction for hypertrophy (11) .
The observed I Ca,L reduction in CREB KO may serve as an explanation for two findings 1) the unaltered hemodynamic comparing CREB KO and CTR mice, and 2) the missing of hypertrophy in the heart of CREB KO mice up to an age of 24 wk (22) . Bearing these studies in mind, one may speculate that CREB KO mice are protected by the reduction of I Ca,L from detrimental effects mediated by an activation of the calcineurin/NFATc3 pathway due to the observed AP prolongation.
Interpreting the results of our study, one has to keep in mind that the inactivation of CREB might be compensated by its family members ATF1, CREM, and derived splice variants (21) . The mRNA encoding the repressory CREM splice variant Icer was downregulated in CREB KO cardiomyocytes, whereas the mRNA level quantified by a primer pair recognizing several other CREM splice variants (e.g., Crem␣) was elevated in CREB KO. Therefore, it cannot be excluded that the observed alterations in CREB KO cardiomyocytes are influenced or partly compensated by other members of the cAMP-dependent transcription factor family.
In conclusion, our results from mice with cardiomyocytespecific inactivation of CREB definitively indicate that CREB is a modulator of the AP shape and duration. CREB regulates the I to amplitude maintaining Kcnd2 gene expression in the adult mouse ventricle, however, likely by an indirect mechanism. Furthermore, CREB inactivation leads to an increase of I Na and decrease of I Ca,L , which might limit myocyte contractility and protect from a hypertrophic response in presence of an AP prolongation. Further work is needed to elucidate the mechanisms in detail leading to the complex electrophysiological phenotype in CREB KO mice and whether these mechanisms are relevant in the context of heart failure-associated ion channel remodeling.
